Sunnybrook Health Sciences Centre takes a comprehensive, team approach in diagnosing and treating prostate cancer, which includes a patient evaluation in screening for prostate cancer, detecting it at its earliest disease stage, providing a patient-oriented treatment plan and subsequent support. Our specialists will define treatment goals based on the specific details of the prostate cancer, previous treatments if any, and quality-of-life issues. Where cure is the goal, we offer state-of-the-art surgical approaches, non-invasive treatments, and advanced radiation therapy.
Where cure is not possible, we offer state-of-the-art treatment approaches to prolong survival and to maximize quality-of-life. The Odette Cancer Center also has leading scientists and clinicians dedicated in prostate cancer research excellence. We have developed many laboratory and clinical advances in the management of prostate cancer that help with our understanding and approach to treating prostate cancer.Visit Sunnybrook Health Sciences Centre website
2075 Bayview Ave, Toronto, ON M4N 3M5, CanadaDirections
Laurence Klotz, CM, MD, is the former Chief of Urology at Sunnybrook Health Sciences Centre, and former chairman of the World Urologic Oncology Federation. He is the chairman of the Canadian Urology Research Consortium and past president of the Canadian Urological Association. He currently serves as Professor of Surgery at the University of Toronto and holds the Sunnybrook Chair in Prostate Cancer Research. He received the Order of Canada, as well as numerous other national and international awards for his work in prostate cancer, including Lifetime Achievement Awards from the Canadian Urological Association and the University of Toronto.
TULSA was invented at Sunnybrook, and Dr. Klotz was involved in the development and evaluation of the technology over the last 20 years. The TULSA team he has assembled is one of the most experienced in the world.
MRI Tech to Radiologist
If you have any questions about the TULSA Procedure, the Profound Medical clinical team with do its best to respond within 72 hours.